Trigger the CBC: Join the Broadcasters Circle today
BC man receives cash payout after vaccine injury

TCS Wire

June 2, 2022

Ross Wightman has become one of the first Canadians to receive compensation for a vaccine injury after being diagnosed with debilitating Guillain-Barre syndrome only days after receiving the COVID vaccine.

man receives compensation vaccine injury

“First and foremost, we would like to offer you our deepest sympathies for your ongoing health struggles. We wish you the strength and support to sustain you during this difficult time and wish to thank you for submitting a claim with the Vaccine Injury Support Program (VISP),” a letter Wightman received and shared with the CBC reads.

“Following an assessment of your case, it has been determined by our Medical Review Board that there is a probable causal association between the injury(ies) sustained and the vaccination. As such, your claim has been approved for compensation.”

“The medical Review Board has also determined the severity of the injury(ies) based on the medical documentation available at the time of assessment. Based on this assessment, you qualify for injury indemnity totalling [redacted]. This indemnity will be paid as a lump sum and is tax exempt.”

Citing privacy concerns, Wightman said he didn’t want to share the total amount he was granted, adding that the highest payout is $284,000, for which he didn’t qualify.

He added that he is also eligible for income replacement of up to $90,000 annually.

Following inoculation with the dangerous COVID vaccine, Wightman subsequently came down with GBS, causing loss of mobility, vision impairment, and several other problems that led to him losing his job as a pilot and real estate investor. He said that while the payments are nice, they’re still less than what he used to make.

“I don’t know what number I can say is enough, but [the payout] is not something that I’m overly excited about,” he said. “The income replacement won’t be what we’ve been used to … so that’s a little disappointing to me.”

Wightman adds that while the paper and the payments don’t change his condition, they are incredibly vindicating.

“That was quite vindicating,” said Wightman. “To have it in hand, in paper, acknowledging it has been vindicating.”

Wightman is one of ten in Canada who’ve been diagnosed with GBS within 30 days of receiving the COVID vaccine. And while Wightman is only one of a few who’ve received compensation following his injury, his case and acknowledgement of the vaccine as causal may pave the way for more vaccine-injured Canadians to be similarly vindicated.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

A new study indicates that the rate of re-infection of COVID is higher for those who are considered fully vaccinated.

Mike Campbell

August 15, 2022

Trending News

Pfizer CEO Albert Bourla unironically tweeted that, despite catching COVID, he was grateful for getting jabbed four times and still requiring another one of his products to treat the infection.

Mike Campbell

August 15, 2022

Trending News

Germany’s health minister, Karl Lauterbach, has unveiled a new COVID tracking app that uses colours based on health status to determine what rights someone has, just like the app used in China.

Keean Bexte

August 10, 2022

Trending News

A study published in July found that 42.1% of women who got a COVID vaccine reported heavier than usual menstrual bleeding following the jab.

Thomas Lambert

August 10, 2022

Trending News

Denmark has announced that people under the age of 18 are no longer allowed to get the COVID vaccine.

Mike Campbell

August 9, 2022

Trending News

As workplaces across Canada call back unvaccinated workers, those fired because of vaccine mandates need to demand lost pay from their employers.

Keean Bexte

August 8, 2022

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.